Prostate Cancer Hormone Therapy Market Size, Share & Industry Analysis, By Drug Class (Androgen Receptor Inhibitors, Gonadotropin Releasing Hormone (GnRH) Agonist, Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist, and Others), By Disease State (Metastatic Castration-Resistant Prostate Cancer and Non-Metastatic Castration-Resistant Prostate Cancer), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2025-2032
Last Updated: December 01, 2025
| Format: PDF
| Report ID: FBI112836